Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13299* | 2021 |
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress MP Kaster, NJ Machado, HB Silva, A Nunes, AP Ardais, M Santana, ... Proceedings of the National Academy of Sciences 112 (25), 7833-7838, 2015 | 312 | 2015 |
Neuropeptide Y stimulates autophagy in hypothalamic neurons CA Aveleira, M Botelho, S Carmo-Silva, JF Pascoal, M Ferreira-Marques, ... Proceedings of the National Academy of Sciences 112 (13), E1642-E1651, 2015 | 83 | 2015 |
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice C Wilke, E Haas, K Reetz, J Faber, H Garcia‐Moreno, MM Santana, ... EMBO molecular medicine 12 (7), e11803, 2020 | 79 | 2020 |
Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress R Faria, MM Santana, CA Aveleira, C Simões, E Maciel, T Melo, ... Neuroscience 273, 1-11, 2014 | 79 | 2014 |
Isolation, characterization, and differentiation of progenitor cells from human adult adrenal medulla MM Santana, KF Chung, V Vukicevic, J Rosmaninho-Salgado, ... Stem cells translational medicine 1 (11), 783-791, 2012 | 58 | 2012 |
Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression J Rosmaninho-Salgado, AP Marques, M Estrada, M Santana, V Cortez, ... Peptides 37 (1), 49-54, 2012 | 49 | 2012 |
Proliferative hypothalamic neurospheres express NPY, AGRP, POMC, CART and Orexin-A and differentiate to functional neurons L Sousa-Ferreira, AR Alvaro, C Aveleira, M Santana, I Brandao, S Kügler, ... PloS one 6 (5), e19745, 2011 | 49 | 2011 |
Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes J Rosmaninho-Salgado, V Cortez, M Estrada, MM Santana, A Gonçalves, ... Neuropeptides 46 (6), 359-366, 2012 | 43 | 2012 |
Simple and fast SEC-based protocol to isolate human plasma-derived extracellular vesicles for transcriptional research LS Gaspar, MM Santana, C Henriques, MM Pinto, TM Ribeiro-Rodrigues, ... Molecular Therapy-Methods & Clinical Development 18, 723-737, 2020 | 38 | 2020 |
Regulation of catecholamine release in human adrenal chromaffin cells by β-adrenoceptors V Cortez, M Santana, AP Marques, A Mota, J Rosmaninho-Salgado, ... Neurochemistry international 60 (4), 387-393, 2012 | 29 | 2012 |
Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3 H Garcia‐Moreno, M Prudencio, G Thomas‐Black, N Solanky, ... European journal of neurology 29 (8), 2439-2452, 2022 | 28 | 2022 |
Molecular mechanisms and cellular pathways implicated in Machado-Joseph disease pathogenesis C Nóbrega, AT Simões, J Duarte-Neves, S Duarte, ... Polyglutamine Disorders, 349-367, 2018 | 24 | 2018 |
Impaired adrenal medullary function in a mouse model of depression induced by unpredictable chronic stress MM Santana, J Rosmaninho-Salgado, V Cortez, FC Pereira, MP Kaster, ... European Neuropsychopharmacology 25 (10), 1753-1766, 2015 | 24 | 2015 |
Polyglutamine‐expanded Ataxin‐3: a target engagement marker for spinocerebellar ataxia type 3 in peripheral blood J Hübener‐Schmid, K Kuhlbrodt, J Peladan, J Faber, MM Santana, ... Movement Disorders 36 (11), 2675-2681, 2021 | 22 | 2021 |
Trehalose alleviates the phenotype of Machado–Joseph disease mouse models MM Santana, S Paixão, J Cunha-Santos, TP Silva, A Trevino-Garcia, ... Journal of Translational Medicine 18, 1-17, 2020 | 22 | 2020 |
Differential temporal dynamics of axial and appendicular ataxia in SCA3 RP Maas, S Teerenstra, M Lima, P Pires, L Pereira de Almeida, ... Movement Disorders 37 (9), 1850-1860, 2022 | 17 | 2022 |
Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease CO Miranda, RJ Nobre, VH Paiva, JV Duarte, J Castelhano, LI Petrella, ... Acta neuropathologica communications 10 (1), 37, 2022 | 10 | 2022 |
Characterization of lifestyle in spinocerebellar ataxia type 3 and association with disease severity H Hengel, P Martus, J Faber, H Garcia‐Moreno, N Solanky, P Giunti, ... Movement Disorders 37 (2), 405-410, 2022 | 10 | 2022 |
Stage‐dependent biomarker changes in spinocerebellar ataxia type 3 J Faber, M Berger, C Wilke, J Hubener‐Schmid, T Schaprian, ... Annals of neurology 95 (2), 400-406, 2024 | 9 | 2024 |